|
VPS37A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46590000138502E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.18079995465359E-09 |
| Normal-vs-Stage2 |
4.611700E-02 |
| Normal-vs-Stage3 |
4.816000E-01 |
| Normal-vs-Stage4 |
1.975410E-01 |
| Stage1-vs-Stage2 |
2.459400E-01 |
| Stage1-vs-Stage3 |
1.059710E-02 |
| Stage1-vs-Stage4 |
3.770400E-01 |
| Stage2-vs-Stage3 |
3.738000E-01 |
| Stage2-vs-Stage4 |
9.804800E-01 |
| Stage3-vs-Stage4 |
5.121200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.50099999599129E-08 |
| Normal-vs-AfricanAmerican |
5.87810000000077E-05 |
| Normal-vs-Asian |
8.461900E-02 |
| Caucasian-vs-AfricanAmerican |
9.556400E-01 |
| Caucasian-vs-Asian |
6.013400E-01 |
| AfricanAmerican-vs-Asian |
5.879200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.99770216930051E-11 |
| Normal-vs-Female |
1.916030E-01 |
| Male-vs-Female |
2.413200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.500340E-03 |
| Normal-vs-Extreme_Weight |
6.66999999676676E-09 |
| Normal-vs-Obese |
2.180300E-03 |
| Normal-vs-Extreme_Obese |
5.903100E-03 |
| Normal_Weight-vs-Extreme_Weight |
2.988400E-01 |
| Normal_Weight-vs-Obese |
6.227800E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.141600E-01 |
| Extreme_Weight-vs-Obese |
7.717900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.835400E-01 |
| Obese-vs-Extreme_Obese |
3.330800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.686400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.68531999999999E-05 |
| Normal-vs-Age(61-80Yrs) |
2.33409958028119E-10 |
| Normal-vs-Age(81-100Yrs) |
1.90810000000319E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.664150E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.283600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.045600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.572000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.549350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.981800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.18958226286759E-12 |
| Normal-VS-Type2 PRCC |
8.042000E-04 |
| Normal-VS-KIRP CIMP |
4.264300E-02 |
| Normal-VS-Unclassified PRCC |
1.856230E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.119500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.075700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.054580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.32440000000378E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.636600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.39279999999909E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.72928999999655E-05 |
| Normal-vs-N1 |
5.093800E-01 |
| Normal-vs-N2 |
9.003000E-01 |
| N0-vs-N1 |
4.508100E-02 |
| N0-vs-N2 |
1.085570E-01 |
| N1-vs-N2 |
6.900800E-01 |
|
|
